Growth Metrics

Lucid Diagnostics (LUCD) Gross Profit Growth (1y) (2022 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.52%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.76%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 4.41%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.59%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 15.74%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.30%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 27.39%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -1.74%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 8.72%
10 Lucid Diagnostics 145.00 Mn 117.12 Mn -325,000.00 55.05%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 55.05%
Dec 31, 2025 169.83%
Sep 30, 2025 -7.18%
Jun 30, 2025 13.20%
Mar 31, 2025 -10.38%
Dec 31, 2024 4.89%
Sep 30, 2024 -238.90%
Jun 30, 2024 -132.66%
Mar 31, 2024 82.21%
Dec 31, 2023 -9,780.36%
Sep 30, 2023 -1,219.74%
Mar 31, 2023 -1,945.00%
Dec 31, 2022 -62.67%
Sep 30, 2022 -62.00%